| P-glycoprotein-mediated drug interactions in pregnancy and changes in the risk of congenital anomalies: a case-reference study ANA Daud, JEH Bergman, MK Bakker, H Wang, WS Kerstjens-Frederikse, ... Drug safety 38, 651-659, 2015 | 52 | 2015 |
| Pharmacogenetics of drug-induced birth defects: the role of polymorphisms of placental transporter proteins ANA Daud, JEH Bergman, MK Bakker, H Wang, HEK De Walle, T Plösch, ... Pharmacogenomics 15 (7), 1029-1041, 2014 | 43 | 2014 |
| Maternal use of drug substrates of placental transporters and the effect of transporter-mediated drug interactions on the risk of congenital anomalies ANA Daud, JEH Bergman, MP Oktora, WS Kerstjens-Frederikse, H Groen, ... PloS one 12 (3), e0173530, 2017 | 21 | 2017 |
| The Risk of Congenital Heart Anomalies Following Prenatal Exposure to Serotonin Reuptake Inhibitors—Is Pharmacogenetics the Key? ANA Daud, JEH Bergman, WS Kerstjens-Frederikse, H Groen, B Wilffert International journal of molecular sciences 17 (8), 1333, 2016 | 17 | 2016 |
| Knowledge and attitude regarding pharmacogenetics among formerly pregnant women in the Netherlands and their interest in pharmacogenetic research ANA Daud, EL Bergsma, JEH Bergman, HEK De Walle, ... BMC pregnancy and childbirth 17, 1-9, 2017 | 15 | 2017 |
| Prenatal exposure to serotonin reuptake inhibitors and congenital heart anomalies: an exploratory pharmacogenetics study ANA Daud, JEH Bergman, WS Kerstjens-Frederikse, P van der Vlies, ... Pharmacogenomics 18 (10), 987-1001, 2017 | 8 | 2017 |
| Serotonin reuptake inhibitors (SRIs) and the risk of fetal congenital heart anomalies (CHA): An exploratory pharmacogenetics study AN Daud, W Frederikse, JEH Bergman, P van der Vlies, E Hak, R Berger, ... Naunyn-Schmiedebergs Archives of Pharmacology 390 (Suppl. 1), S24-100, 2017 | | 2017 |
| Supplementary Materials: The Risk of Congenital Heart Anomalies Following Prenatal Exposure to Serotonin Reuptake Inhibitors—Is Pharmacogenetics the Key? ANA Daud, JEH Bergman, WS Kerstjens-Frederikse, H Groen, B Wilffert Int. J. Mol. Sci 17, 1333, 2016 | | 2016 |
| The effect of P-glycoprotein-mediated drug interactions in pregnancy on the risk of congenital anomalies ANA Daud, JEH Bergman, MK Bakker, H Wang, WS Kerstjens-Frederikse, ... PHARMACOEPIDEMIOLOGY AND DRUG SAFETY 24, 30-31, 2015 | | 2015 |
| Research Report 1: Drug Interaction in Pregnancy: The Role of Placental Transporter Proteins in Fetal Drug Exposure MP Oktora, B Wilffert, ANA Daud Faculty of Science and Engineering, 2015 | | 2015 |
| Patient-reported side effects of lamotrigine during routine clinic visits NA Daud, AF Ab-Rahman Neurosciences Journal 17 (3), 269-270, 2012 | | 2012 |
| Metformin in gestational diabetes (MeGDia): A multicenter study on the knowledge, attitude and practice among Malaysian health care professionals ANA Daud, SN Harun, SMS Ghadzi, OY Ping, F Yusof, F Yusoff | | |
Marian K BakkerUniversity Medical Center Groningen, Groningen, The NetherlandsVerified email at umcg.nl
Marian K BakkerUniversity Medical Center Groningen, Groningen, The NetherlandsVerified email at umcg.nl